DUBLIN, Nov. 15, 2018 /PRNewswire/ --
The "Continuous Glucose Monitoring (CGM) Systems/Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Insulin Pumps), By End Use (Hospitals, Homecare), And Segment Forecasts, 2018 - 2024" report has been added to ResearchAndMarkets.com's offering.
The global continuous glucose monitoring (CGM) devices market size is expected to reach USD 1.01 billion by 2024. The market is estimated to register a CAGR of 13.7% over the forecast period.
Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth.
These devices help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth.
With the advent of digital therapeutics, a rising number of CGM devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward market growth.
Key Findings
Key Topics Covered
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Continuous Glucose Monitoring Devices Market - Industry Summary and Key Buying Criteria, 2013 - 2024
Chapter 3. Continuous Glucose Monitoring Devices Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2013 - 2024
3.3. Continuous Glucose Monitoring Devices: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing number of diabetes patients globally
3.3.1.2. Easy and efficient monitoring of current glucose values
3.3.2. Market restraint analysis
3.3.2.1. High surge in the price and cost of treatment
3.4. Continuous Glucose Monitoring Devices Market: Industry trend analysis
3.5. Continuous Glucose Monitoring Devices Market: PESTEL Analysis
3.6. Continuous Glucose Monitoring Devices Industry Analysis - Porter's Five Forces Model
3.7. Continuous Glucose Monitoring Devices: Company market share analysis (%), 2015
3.8. Key opportunities prioritized
Chapter 4. Continuous Glucose Marketing Product Outlook
4.1. Continuous Glucose Monitoring Revenue Share (%) Analysis, by Product, 2016 & 2024
4.2. Transmitters and Receivers
4.3. Sensors
4.4. Insulin Pumps
Chapter 5. Continuous Glucose Monitoring End-user Outlook
5.1. Continuous Glucose Monitoring Revenue Share (%) Analysis, by End-user, 2016 & 2024
5.2. Hospital
5.3. Homecare Diagnostics
5.4. Others
Chapter 6. Continuous Glucose Monitoring Regional Outlook
6.1. Continuous Glucose Monitoring Market Share (%) Analysis, by Region, 2014 & 2024
6.2. North America
6.3. Europe
6.4. Asia Pacific
6.5. MEA
6.6. Latin America
Chapter 7. Competitive Landscape
7.1. Roche Diagnostics
7.2. Dexcom Inc.
7.3. Abbott Laboratories
7.4. Medtronic Inc.
7.5. Animas Corporation
7.6. Novo Nordisk
7.7. Ypsomed AG
7.8. GlySens Incorporated
For more information about this report visit https://www.researchandmarkets.com/research/czcxgd/opportunity?w=5
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
These press releases may also interest you
|